Cancel
insitro
See Linkedin
insitro Employees
102 people indexed:
-
85p72@j9b1w67.l1h Sign up to see email
-
bgw8@y115pyh.v96 Sign up to see email
-
03x2j@zq6u49y.b85 Sign up to see email
-
37b74@u5qkq60.j7d Sign up to see email
-
6p0z6u@65hfxxv.1bq Sign up to see email
-
ejxh@eu8q9xx.huu Sign up to see email
-
u12w37@538ujzl.8vl Sign up to see email
-
1v6xp@07d0yxh.k6z Sign up to see email
-
1z898@4vz2z0l.uxx Sign up to see email
-
y496p@3qdqp5z.qdq Sign up to see email
-
78b9hv@jh6j5qh.jxg Sign up to see email
-
0l1@8pz44w7.2vu Sign up to see email
-
0qkzl6@u3f15fl.ay7 Sign up to see email
-
4qg9h@621zuuw.25z Sign up to see email
-
920f1@ahl2x4k.hzk Sign up to see email
-
kyyf99@04uf21q.y0g Sign up to see email
-
8k15p@76dvv2e.7ud Sign up to see email
-
81ghx@x0q13bw.zj7 Sign up to see email
-
fq626@4gv302k.0hk Sign up to see email
-
25bp33ww1@kylbj9d.lxp Sign up to see email
-
005q5@5f494qk.710 Sign up to see email
-
pbx99p@xxfu418.90p Sign up to see email
-
6zu66ux@7k6u58q.zgq Sign up to see email
-
q4kxyu40q@f6d0j2x.5v0 Sign up to see email
-
3690@1xk34y3.waa Sign up to see email
-
4805wx@lxwbukj.q97 Sign up to see email
-
78zy@1pbzl3j.zj8 Sign up to see email
-
kugup@1yg68h5.hk9 Sign up to see email
-
p7g9j@qg3z6x1.51q Sign up to see email
-
w9b5e@ye0eheh.h03 Sign up to see email
-
j982g@uq73vl6.bj2 Sign up to see email
-
bzu2l@lx3wb9u.7ba Sign up to see email
-
91ygq@4xk30g6.axk Sign up to see email
-
kh06l@4fwe14w.5hq Sign up to see email
-
6p5fb@82z1g1u.821 Sign up to see email
-
ujxqv@wpblfkh.zhp Sign up to see email
-
29lgl2@6750j7l.qfg Sign up to see email
-
kgj0df4j0@34xfgfq.7u9 Sign up to see email
-
42fp@99w2llx.lh2 Sign up to see email
-
Eva-Maria Krauel
Director, Project and Portfolio Management
p0y38lj8q@w98p4gw.8l4 Sign up to see emailu4pbw5dg1@lz1wuj3.byq Sign up to see email -
6be0@885qdyj.e45 Sign up to see email
-
qjwxufk@b0909fv.vf6 Sign up to see email
-
b18pwp@p5bfugw.3wf Sign up to see email
-
9yuy3zg@x8upz7z.gwp Sign up to see email
-
22q28g@bxy22df.lp4 Sign up to see email
-
g1q6@8kyhdaf.wxg Sign up to see email
-
b5107l@9kdw3ba.87q Sign up to see email
-
fup@d5612v1.9kf Sign up to see email
-
xgll@135d8yy.9g8 Sign up to see email
-
9yp3@3816ek7.u3e Sign up to see email
-
9qud@72f2b40.a2u Sign up to see email
-
0yvgz4qg@5948v3x.vy8 Sign up to see email
-
xkkw4lq4@32w520z.2b6 Sign up to see email
-
Jordi Serrats
Senior Director, Neuroscience Drug Discovery Biology
uz1el@042yavz.v33 Sign up to see emailvbzgv@h1l5apb.8hu Sign up to see email -
4lbu@8ezq29k.w0z Sign up to see email
-
z3xhh1y@9dwuy1u.1gz Sign up to see email
-
z260@0jw8gf2.0h9 Sign up to see email
-
05h0@wjj53dz.u6j Sign up to see email
-
9vuf0pb@jp0el71.g80 Sign up to see email
-
Katie Jackson
Senior Director, People & Organizational Development
q1l5q@du9fx77.qy3 Sign up to see email76l53@udfj5pl.w3f Sign up to see email -
z1qzbj@ww141h4.8fw Sign up to see email
-
p0gpw@w3u06dd.11f Sign up to see email
-
4w3638@x9uu59u.d1d Sign up to see email
-
Kristina Green
VP, Bioassays and Cell Based Arrayed Screening
pp9v2u21@f3jq0lj.pfj Sign up to see email90vwj9df@ly22v2e.j3e Sign up to see email -
0h6g1l6@xzwfwqf.4d1 Sign up to see email
-
u8vf@bzf5kqf.xvg Sign up to see email
-
j4v4y@ga7g2f0.w25 Sign up to see email
-
68h7uhw4@fj4wyjh.b59 Sign up to see email
-
xb5wypqpv@42ph4jp.352 Sign up to see email
-
Martin Suen
Associate Director, Environmental Health and Safety
xyuv50@3defbgz.p11 Sign up to see emailj7he19@6eq4xbp.4j3 Sign up to see email -
jfjxqw7@8zxdpj1.147 Sign up to see email
-
2eb@310h76e.bje Sign up to see email
-
60g@8k2g5be.gje Sign up to see email
-
d9lwwb9@q5kx5b4.290 Sign up to see email
-
ywvpd53@dvuhu24.d89 Sign up to see email
-
5jy8wpuk@55y14ff.qjw Sign up to see email
-
wjwd@1lyx4y1.6b2 Sign up to see email
-
f86d@3d45up3.58d Sign up to see email
-
qjlu6qq@1v7u0ge.6ge Sign up to see email
-
xdu2z6@5q47ka2.820 Sign up to see email
-
87wk64@70zzaga.6fv Sign up to see email
-
kyga9a2@x4uzzu7.4wz Sign up to see email
-
x7z647@yzf2uzd.a4b Sign up to see email
-
dfk63@0zw0823.f0w Sign up to see email
-
fyp5p4@2bq2g67.6zh Sign up to see email
-
lh3@xzu9eyv.j9q Sign up to see email
-
022q28@0ph227q.ddx Sign up to see email
-
py9p9591@de0wwj6.dj4 Sign up to see email
-
Sarah Peruzzaro
Scientist II, Neuroscience, Translational Medicine
l3lfx@kw3fw83.3fp Sign up to see emailel130@e3gv0q4.05q Sign up to see email -
vup@43h5ybx.fu0 Sign up to see email
-
Shira Becker
Associate Director, Corporate & Strategic Finance
4x774@w8g6ez7.6y4 Sign up to see emaildveeq@1dpqy1u.xqd Sign up to see email -
u61uy2lq7@3gd46u2.xw0 Sign up to see email
-
wll6p@hk74b1w.4px Sign up to see email
-
89z6qv@15g4879.jz2 Sign up to see email
-
2kfu1j@63339g2.e3b Sign up to see email
-
7fhv@y28kf0y.1xq Sign up to see email
-
6lfbfek@kw5abe2.qfq Sign up to see email
-
bd9xf9@6ye6d80.lyl Sign up to see email
-
xfad6e@7052gw1.g7u Sign up to see email
-
bzxkw@6eqe8uq.6g6 Sign up to see email
-
19zgyx@044ka9p.fxk Sign up to see email
-
u1eg@ewy7fpj.qp8 Sign up to see email
insitro Company Information
Insitro is a pioneering biotechnology firm based in South San Francisco, California, at 279 East Grand Avenue. The company utilizes a machine learning-driven platform that integrates in vitro cellular data with human clinical data to redefine disease understanding and accelerate the development of new medicines. Insitro has raised $400 million in Series C financing to advance its capabilities in machine learning for drug discovery. It is actively building a pipeline of therapeutic programs targeting significant unmet needs in metabolism, oncology, and neuroscience. The company’s research focuses on diseases such as metabolic-associated steatotic liver disease (MASLD), obesity, and neurodegenerative conditions like Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, in partnership with Bristol Myers Squibb. Insitro’s approach includes generating multi-modal phenotypic cellular data in automated laboratories and aggregating clinical data from human cohorts to fuel its machine learning and generative AI technologies. By leveraging human genetics, Insitro identifies causal intervention points in diseases, aiming to transform these insights into effective therapeutic interventions. The company also employs machine learning-enabled analysis of histopathology images to gain novel insights into the biology of the tumor microenvironment, enhancing its research and development efforts.
Report inaccurate information
Report inaccurate information
